Practice patterns, gaps, and priorities in infection management for patients receiving bispecific antibodies and CAR-T cell therapy – Results from the E-Impact survey of the EHA-SWG infections in hematology

Bispecific antibodies (BsAbs) and chimeric antigen receptor T-cell (CAR-T) therapies have transformed the treatment of hematologic malignancies, but infectious complications remain a leading cause of morbidity and mortality. We conducted a multicenter international survey across 101 institutions—predominantly academic tertiary hospitals (80.2%)—to characterize contemporary prevention and management practices. We assessed antimicrobial prophylaxis, infection surveillance, and management of therapy-induced immunodeficiency for patients receiving BsAbs and/or CAR-T. Practices were highly heterogeneous. According to respondents’ perception, viral infections were the most frequent with BsAbs (69.3%), whereas bacterial infections predominated after CAR-T (52.8%). Anti–Pneumocystis jirovecii prophylaxis was nearly universal (93.5% BsAbs; 97.5% CAR-T), but antibacterial and antifungal prophylaxis varied widely and were omitted in 86% and 38.7% of BsAb centers, respectively. CMV monitoring strategies differed markedly; one-third of BsAb centers did not routinely monitor CMV-DNA. Most respondents identified better guidelines (72.3% BsAbs; 52.8% CAR-T), improved diagnostic tools, and multidisciplinary approaches as priorities. These findings underscore substantial practice variation and the urgent need for harmonized, evidence-based guidance, particularly in light of recent data highlighting prolonged hypogammaglobulinemia, infection burden per patient-month with continuously dosed BsAbs, and the potential protective effect of immunoglobulin replacement. Prospective studies are warranted to define optimal prophylaxis, surveillance, and immunoglobulin replacement strategies in these populations.

Authors

Institutions

Publication Details

Journal
Annals of Hematology
Published
2026-11-17
DOI
https://doi.org/10.1007/s00277-026-07358-6
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Practice patterns, gaps, and priorities in infection management for patients receiving bispecific antibodies and CAR-T cell therapy – Results from the E-Impact survey of the EHA-SWG infections in hematology

Jon Salmanton-Garcia, Livio Pagano, Oliver A. Cornely, María Stefania Infante et al.
4 links
Annals of Hematology
Neutropenia and Cancer Infections
article

Practice patterns, gaps, and priorities in infection management for patients receiving bispecific antibodies and CAR-T cell therapy – Results from the E-Impact survey of the EHA-SWG infections in hematology

Jon Salmanton-Garcia, Livio Pagano, Oliver A. Cornely, María Stefania Infante, Sigrun Einarsdottir
article en

Abstract

Bispecific antibodies (BsAbs) and chimeric antigen receptor T-cell (CAR-T) therapies have transformed the treatment of hematologic malignancies, but infectious complications remain a leading cause of morbidity and mortality. We conducted a multicenter international survey across 101 institutions—predominantly academic tertiary hospitals (80.2%)—to characterize contemporary prevention and management practices. We assessed antimicrobial prophylaxis, infection surveillance, and management of therapy-induced immunodeficiency for patients receiving BsAbs and/or CAR-T. Practices were highly heterogeneous. According to respondents’ perception, viral infections were the most frequent with BsAbs (69.3%), whereas bacterial infections predominated after CAR-T (52.8%). Anti–Pneumocystis jirovecii prophylaxis was nearly universal (93.5% BsAbs; 97.5% CAR-T), but antibacterial and antifungal prophylaxis varied widely and were omitted in 86% and 38.7% of BsAb centers, respectively. CMV monitoring strategies differed markedly; one-third of BsAb centers did not routinely monitor CMV-DNA. Most respondents identified better guidelines (72.3% BsAbs; 52.8% CAR-T), improved diagnostic tools, and multidisciplinary approaches as priorities. These findings underscore substantial practice variation and the urgent need for harmonized, evidence-based guidance, particularly in light of recent data highlighting prolonged hypogammaglobulinemia, infection burden per patient-month with continuously dosed BsAbs, and the potential protective effect of immunoglobulin replacement. Prospective studies are warranted to define optimal prophylaxis, surveillance, and immunoglobulin replacement strategies in these populations.

Annals of Hematology
Memorial Sloan Kettering Cancer Center (US), University of Cologne (DE), Sahlgrenska University Hospital (SE), Agostino Gemelli University Polyclinic (IT), Research Institute Hospital 12 de Octubre (ES), Düsseldorf University Hospital (DE), Hospital Universitario 12 De Octubre (ES), German Center for Infection Research (DE), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE)
Univerzita Komenského v Bratislave, İstanbul Medeniyet Üniversitesi, Universität Wien, Università degli Studi di Padova, Universidad Autónoma de Nuevo León, Shanghai Jiao Tong University, Università Cattolica del Sacro Cuore, Medizinische Universität Wien, Aristotle University of Thessaloniki, Fakultní Nemocnice Plzen, Università degli Studi di Torino, Sjællands Universitetshospital, School of Medicine, Shanghai Jiao Tong University, National Cancer Institute, Cliniques Universitaires Saint-Luc
Good health and well-being
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon